Literature DB >> 36213772

Estimating correlations between vaccine clinical trial outcomes.

Alexey Rey1, Olga Rozanova1, Sergey Zhuk1.   

Abstract

We demonstrate how a linear factor model with latent variables can be used to estimate correlations between the outcomes of clinical trials. These correlations are needed for many policy questions of drug/vaccine development (such as calculating the optimal size of financial incentives) and the literature so far has relied on expert opinions. We apply our methodology to the case of vaccines and show that the estimated correlations are highly significant. We also illustrate how the estimated correlations can be used to find the probability of obtaining a successful vaccine out of a certain number of candidates and to determine optimal investment in vaccine development.
© 2021 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  62P10; 62P20; 62Pxx; Applications of statistics; clinical trials; correlations; factor models; latent variables; maximum likelihood

Year:  2021        PMID: 36213772      PMCID: PMC9542939          DOI: 10.1080/02664763.2021.1949439

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  10 in total

1.  Two-dimensional toxic dose and multivariate logistic regression, with application to decompression sickness.

Authors:  Jialiang Li; Weng Kee Wong
Journal:  Biostatistics       Date:  2010-07-05       Impact factor: 5.899

2.  Classical latent variable models for medical research.

Authors:  Sophia Rabe-Hesketh; Anders Skrondal
Journal:  Stat Methods Med Res       Date:  2007-09-13       Impact factor: 3.021

Review 3.  Vaccine development costs: a review.

Authors:  Arianna Waye; Philip Jacobs; Anthony B Schryvers
Journal:  Expert Rev Vaccines       Date:  2013-10-25       Impact factor: 5.217

4.  Market design to accelerate COVID-19 vaccine supply.

Authors:  Juan Camilo Castillo; Amrita Ahuja; Susan Athey; Arthur Baker; Eric Budish; Tasneem Chipty; Rachel Glennerster; Scott Duke Kominers; Michael Kremer; Greg Larson; Jean Lee; Canice Prendergast; Christopher M Snyder; Alex Tabarrok; Brandon Joel Tan; Witold Więcek
Journal:  Science       Date:  2021-02-25       Impact factor: 47.728

5.  Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials.

Authors:  Sheng Wu; Catherine M Crespi; Weng Kee Wong
Journal:  Contemp Clin Trials       Date:  2012-05-22       Impact factor: 2.226

6.  Innovation in the pharmaceutical industry: New estimates of R&D costs.

Authors:  Joseph A DiMasi; Henry G Grabowski; Ronald W Hansen
Journal:  J Health Econ       Date:  2016-02-12       Impact factor: 3.883

7.  A random-effects ordinal regression model for multilevel analysis.

Authors:  D Hedeker; R D Gibbons
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

8.  Parallel discovery of Alzheimer's therapeutics.

Authors:  Andrew W Lo; Carole Ho; Jayna Cummings; Kenneth S Kosik
Journal:  Sci Transl Med       Date:  2014-06-18       Impact factor: 17.956

9.  Risk in vaccine research and development quantified.

Authors:  Esther S Pronker; Tamar C Weenen; Harry Commandeur; Eric H J H M Claassen; Albertus D M E Osterhaus
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

10.  Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study.

Authors:  Dimitrios Gouglas; Tung Thanh Le; Klara Henderson; Aristidis Kaloudis; Trygve Danielsen; Nicholas Caspersen Hammersland; James M Robinson; Penny M Heaton; John-Arne Røttingen
Journal:  Lancet Glob Health       Date:  2018-10-18       Impact factor: 26.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.